[1]
Chang KC, Jeong JH, Kim MK, Wee WR, Lee JH, Jeon BS. The effect of amantadine on corneal endothelium in subjects with Parkinson's disease. Ophthalmology. 2010 Jun:117(6):1214-9. doi: 10.1016/j.ophtha.2009.10.039. Epub 2010 Feb 13
[PubMed PMID: 20153901]
[2]
Esquenazi S. Bilateral reversible corneal edema associated with amantadine use. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 2009 Dec:25(6):567-70. doi: 10.1089/jop.2009.0029. Epub
[PubMed PMID: 20028266]
[3]
Kubo S, Iwatake A, Ebihara N, Murakami A, Hattori N. Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literature. Parkinsonism & related disorders. 2008:14(2):166-9
[PubMed PMID: 17509924]
Level 3 (low-level) evidence
[4]
Yang Y, Teja S, Baig K. Bilateral corneal edema associated with amantadine. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2015 Oct 20:187(15):1155-1158. doi: 10.1503/cmaj.140542. Epub 2015 May 19
[PubMed PMID: 25991839]
[5]
Daggumilli S, Vanathi M, Ganger A, Goyal V, Tandon R. Corneal Evaluation in Patients With Parkinsonism on Long-Term Amantadine Therapy. Cornea. 2019 Sep:38(9):1131-1136. doi: 10.1097/ICO.0000000000001951. Epub
[PubMed PMID: 30973404]
[6]
Lee PY, Tu HP, Lin CP, Chang CH, Cheng KC, Lin CC, Hsu SL. Amantadine Use as a Risk Factor for Corneal Edema: A Nationwide Cohort Study in Taiwan. American journal of ophthalmology. 2016 Nov:171():122-129. doi: 10.1016/j.ajo.2016.08.034. Epub 2016 Sep 2
[PubMed PMID: 27594137]
[7]
Koenig SB, McDermott ML, Simons KB. Nonimmunologic graft failure after Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for presumed amantadine-induced corneal edema. Eye & contact lens. 2009 Jul:35(4):209-11. doi: 10.1097/ICL.0b013e3181a6936f. Epub
[PubMed PMID: 19516146]
[8]
Abib FC, Barreto Junior J. Behavior of corneal endothelial density over a lifetime. Journal of cataract and refractive surgery. 2001 Oct:27(10):1574-8
[PubMed PMID: 11687354]
[9]
Kwon JW, Cho KJ, Kim HK, Lee JK, Gore PK, McCartney MD, Chuck RS. Analyses of Factors Affecting Endothelial Cell Density in an Eye Bank Corneal Donor Database. Cornea. 2016 Sep:35(9):1206-10. doi: 10.1097/ICO.0000000000000921. Epub
[PubMed PMID: 27310882]
[10]
French DD, Margo CE. Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration. Cornea. 2007 Oct:26(9):1087-9
[PubMed PMID: 17893540]
[11]
Chang KC, Kim MK, Wee WR, Lee JH. Corneal endothelial dysfunction associated with amantadine toxicity. Cornea. 2008 Dec:27(10):1182-5. doi: 10.1097/ICO.0b013e318180e526. Epub
[PubMed PMID: 19034138]
[12]
Jeng BH, Galor A, Lee MS, Meisler DM, Hollyfield JG, Schoenfield L, McMahon JT, Langston RH. Amantadine-associated corneal edema potentially irreversible even after cessation of the medication. Ophthalmology. 2008 Sep:115(9):1540-4. doi: 10.1016/j.ophtha.2008.03.011. Epub 2008 May 23
[PubMed PMID: 18501429]
[13]
González Della Valle A, Ruzo PS, Salvati EA. Warfarin-associated intracapsular hemorrhage causing an acutely painful total hip arthroplasty: a rare complication of prolonged anticoagulant therapy. The Journal of arthroplasty. 2000 Aug:15(5):668-70
[PubMed PMID: 10960007]
[14]
Feng MT, Price FW Jr, McKee Y, Price MO. Memantine-associated corneal endothelial dysfunction. JAMA ophthalmology. 2015 Oct:133(10):1218-20. doi: 10.1001/jamaophthalmol.2015.2476. Epub
[PubMed PMID: 26248040]
[15]
Mancera N, Wadia HP. Corneal Edema Associated With Systemic Dopaminergic Agents. Cornea. 2019 Aug:38(8):1040-1042. doi: 10.1097/ICO.0000000000001941. Epub
[PubMed PMID: 30950895]
[16]
Naumann GO, Schlötzer-Schrehardt U. Amantadine-associated corneal edema. Ophthalmology. 2009 Jun:116(6):1230-1; author reply 1231. doi: 10.1016/j.ophtha.2009.01.006. Epub
[PubMed PMID: 19486806]
Level 3 (low-level) evidence
[17]
Hessen MM, Vahedi S, Khoo CT, Vakili G, Eghrari AO. Clinical and genetic investigation of amantadine-associated corneal edema. Clinical ophthalmology (Auckland, N.Z.). 2018:12():1367-1371. doi: 10.2147/OPTH.S166384. Epub 2018 Aug 6
[PubMed PMID: 30122888]
[18]
Patel SV, Hodge DO, Treichel EJ, Spiegel MR, Baratz KH. Predicting the Prognosis of Fuchs Endothelial Corneal Dystrophy by Using Scheimpflug Tomography. Ophthalmology. 2020 Mar:127(3):315-323. doi: 10.1016/j.ophtha.2019.09.033. Epub 2019 Sep 27
[PubMed PMID: 31685256]
[19]
van Cleynenbreugel H, Remeijer L, Hillenaar T. Cataract surgery in patients with Fuchs' endothelial corneal dystrophy: when to consider a triple procedure. Ophthalmology. 2014 Feb:121(2):445-53. doi: 10.1016/j.ophtha.2013.09.047. Epub 2013 Nov 26
[PubMed PMID: 24289914]